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Diabetes distress is common among patients with type 2 diabetes mellitus (T2DM), which 
remains unrecognized in primary care settings. A higher level of diabetes distress was found among 
T2DM patients with comorbidities. The objectives of this study are to assess the prevalence rate of 
diabetes distress and its association with sociodemographic factors among T2DM patients using 
antihypertensive medication in Bandung City, Indonesia. An observational cross-sectional survey was 
performed in six community health centres in Bandung City, Indonesia, among T2DM patients aged at 
least 18 years who were using antihypertensive medications. Diabetes distress subscales (emotional, 
regimen, interpersonal, and physician-related distress) were evaluated using the validated Diabetes 
Distress Scale. Pearson χ2 and Mann–Whitney tests were performed to assess the associations of 
patients’ sociodemographic factors (age, gender, insurance type, education, and duration since 
diagnosed with diabetes and hypertension) with diabetes distress. Of 105 patients who participated and 
completed the survey (response rate 93.8%), most of them were female and were aged 60-69 years. A 
total of 38 patients (36.2%) had moderate-high diabetes distress with emotional (56.2%) and regimen 
(53.3%) distress as the most commonly reported distress. Moderate-high emotional and regimen 
diabetes distress were significantly higher among the elderly (p 0.014) and patients who could not 
afford to pay the health insurance premium (p 0.012). Emotional and regimen distress as dominant 
forms of diabetes distress was observed among T2DM patients using antihypertensive medications. A 
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Diabetes mellitus is one of the most common non-communicable diseases which is experienced 
by more than 400 million people around the world and expected to be the 7th  cause of mortality by 
2030 (Ogurtsova et al., 2017). In Indonesia, 10.3 million of patients with diabetes was reported in 
2017 and this number was estimated to increase to 16.7 million of patients by 2045 (International 
Diabetes Federation, 2017). Management of type 2 diabetes mellitus (T2DM) requires patients to 
engage in regular physical activity, follow a healthy diet, monitor blood glucose levels, and take 
diabetes medication (American Diabetes Association, 2019a). However, incorporating these lifetime 
self-management plans into patients’ daily life can be challenging (Carls et al., 2017). 
Diabetes distress refers to the psychological and emotional responses to the burden and stress 
related to the management of diabetes (Polonsky et al., 2005). Different types of diabetes distress, that 
is, emotional, regimen, physician, and interpersonal-related distress are representing different sources 
of distress (Polonsky et al., 2005). About a quarter of patients experiencing diabetes distress in 
developed countries (Dennick et al., 2015), while this number is expected to be higher in developing 
countries (Chew et al., 2016). Furthermore, 17.2% of those with no diabetes distress at the first 
evaluation are more likely to experience a high level of diabetes distress in the following 18 months 
(Fisher et al., 2009). 
Diabetes distress was related to fewer self-care behaviors (Fisher et al., 2012), lower quality of 
life (Bruno et al., 2019; Chew et al., 2015), suboptimal glycaemic control (Fisher et al., 2010), and 
increased morbidity (Fisher et al., 2007). Therefore, assessing and monitoring diabetes distress is 
recommended as part of clinical care in developed countries (American Diabetes Association, 2019b). 
However, the implementation of routine assessment of diabetes distress lacks in Indonesia (Arifin et 
al., 2019). 
T2DM patients in Indonesian primary health  care  experienced more distress compared to those 
in tertiary health care settings (Arifin et al., 2019). The lack of emotional support from family and 
healthcare providers as well as difficulty to manage the burden of comorbidities such as hypertension, 
may contribute to an increase of diabetes distress (Emre et al., 2018; Wardian and Sun, 2014). Among 
T2DM patients, antihypertensive can be perceived by patients as co-medication, which may give 
particular problems that need to be addressed. However, this problem is not well addressed when 
designing health interventions in primary care settings. To develop tailor intervention according to the 
individual patient’s needs, insight into the magnitude of diabetes distress and associated determinants 
among T2DM patients with comorbidity is needed. The objectives of this study are to assess the 
prevalence rate of diabetes distress and its association with sociodemographic factors among T2DM 
patients using antihypertensive in Bandung City, Indonesia. 
  
MATERIALS AND METHOD  
A cross-sectional survey was performed in Bandung City, Indonesia, from October 2018 to 
September 2019. Patients were recruited from six purposively selected Community Health Centres 
(CHCs) according to a sufficient number of T2DM patients diagnosed with hypertension. CHCs are 
primary health care centres staffed with health care providers such as doctors, nurses, midwives, and 
pharmacists, which provide integrated chronic disease management programs at the sub district level. 
The study has been approved by the Health Research Ethics Committee of Universitas Padjadjaran No. 
1137/UN6.KEP/EC/2018. Informed consent has been obtained from all patients participated in this 
study.  
Patients aged at least 18 years, diagnosed with T2DM for more than one year, using 
antihypertensive medications, and literate in the Indonesian language were eligible to participate. We 
excluded patients who were not able to take their own medication, with severe physical or mental 
constraints, were pregnant, or were in the lactation period. Pharmacists at the CHC screened for 
patients’ eligibility and informed the researcher or trained research assistant when a patient was 
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eligible to explain and describe the study and to ask them to sign the informed consent statement. We 
asked eligible patients to complete a self-reported questionnaire independently. In some cases, 
however, elderly patients who could not read and/or answer the questionnaires were interviewed by 
trained research assistants.   
Distress associated with the burdens of managing diabetes was measured using the Diabetes 
Distress Scale (DDS-17) (Polonsky et al., 2005). The DDS consists of 17 items evaluating the distress 
experienced by the patients last month using four subscales, that is, emotional-related distress (five 
items, e.g., “feeling angry, scared, and/or depressed when I think about living with diabetes”), 
physician-related distress (four items, e.g., “feeling that my doctor doesn’t take my concerns seriously 
enough”), regimen-related distress (five items, e.g., “feeling that I am often failing with my diabetes 
routine),  and interpersonal-related distress (three items, e.g., “feeling that friends or family do not 
appreciate how difficult living with diabetes can be). Patients’ responses in each subscale were added 
and divided by the total number of items in that specific subscale. Based on clinical validation of the 
DDS, the total score was classified into three groups, that is,  those with a total score less than 2.0 
(mild distress), between 2.0 and 2.9 (moderate distress), and  3.0 (high distress) (Fisher et al., 2012). 
To develop tailored intervention, it is important to recognize the patients who need additional support 
as early as possible. Therefore, we combined patients with moderate and high distress. The DDS in the 
Indonesian version was reported to be valid and reliable (Arifin et al., 2017). 
We collected the patient’s sociodemographic factors, that is, gender, age, education completed 
(without formal education or elementary school, junior and senior high school, or university), and 
health insurance type. Health insurance type was defined as patients who could not afford to pay the 
health insurance premium (BPJS-PBI), patients who afford to pay the health insurance premium 
(BPJS-Non PBI), or patients who do not have health insurance. A structured case report form was used 
to record the duration of diabetes and hypertension (years). 
The minimum sample size was calculated by the Slovin formula (Almeda et al., 2010). A 
minimum of 100 patients was required to obtain a margin error of 0.05 and a 95% confidence level. 
 
Data Analysis  
Descriptive statistics were performed to describe the patient characteristics. Pearson χ2 and 
Mann–Whitney tests were performed to evaluate the associations between patients’ 
sociodemographic factors and diabetes distress. Since there were few missing data, we conducted 
complete-case analyses. SPSS software (version 25.0; IBM, Armonk, NY, USA) was used to 
analyze all statistical tests.   
 
RESULT AND DISCUSSION  
Of 105 patients who completed the survey with a response rate of 93.8%., the majority of them 
were female and were aged 60-69 years (Table 1). A total of 38 patients (36.2%) had moderate-high 
diabetes distress (Table 1). The prevalence rate of high diabetes distress was reported between 18 to 
35% (Abdulbari Bener, 2011; L. Fisher et al., 2009, 2010).  The relatively high prevalence rate of 
diabetes distress in our study might be due to the combination of moderate and high diabetes distress. 
Although the disease onset is reported as one of the significant factors related to distress (Hannonen et 
al., 2015), T2DM patients are more likely to develop diabetes distress across the nature course of the 
disease. Therefore, to prevent the negative impacts of diabetes distress, we assume that early support is 
needed once patients identified with at least moderate diabetes distress.  
Most of the patients reported with high-moderate emotional (56.2%) and regimen distress 
(53.3%) (Figure 1). Emotional distress was reported as the dominant form of diabetes distress among 
patients with T2DM as compared to other domains of distress in previous studies (Gahlan et al., 2018; 
Rubin and Peyrot, 1999; Zanchetta et al., 2016). The higher prevalence rate of emotional distress 
might be because patients perceived implementing self-management, self-care and other psychological 
activities as a difficult aspects. Our findings indicating support is needed to target emotional and 
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regimen distress when managing diabetes distress in T2DM patients using antihypertensive 
medications. We further observed that the majority of patients had mild physician distress. This can be 
explained by the satisfaction of T2DM patients toward the physicians in the CHCs. A good 
relationship between patients and physicians is important for the patients’ involvement in their health 
care, which may influence their health outcomes (Chipidza et al., 2015). 
.  
Table 1. Patient characteristics (N = 105) 
Characteristic N (%) 
Gender  
  Male 26 (24.8) 
  Female 79 (75.2) 
Age in years  
  ≤ 49 8 (7.6) 
  50–59 25 (23.8) 
  60–69 44 (41.9) 
  ≥ 70 26 (24.8) 
  Missing 2 (1.9) 
Type of insurance  
  BPJS-PBI 44 (41.9) 
  BPJS-Non PBI 52 (49.5) 
  Without insurance 9 (8.6) 
Last education level   
  Without formal education /    
  elementary school 32 (30.5) 
  Junior high school 25 (23.8) 
  Senior high school 37 (35.2) 
  University 9 (8.6) 
  Missing 2 (1.9) 
Time from diagnosis, years  
  Diabetes, mean (SD) 4.0 (3.9) 
  Missing 10 
Hypertension, mean 9SD) 5.1 (5.5) 
Missing 14 
Diabetes Distress  
  Mild 66 (62.9) 
  Moderate 38 (36.2) 
  Missing 1 (1.0) 
Abbreviations: BPJS-PBI: patients who could not afford to pay the health insurance premium, BPJS-Non PBI: 
patients who afford to pay the health insurance premium, SD: standard deviation 
 
We further analyzed the subscales of diabetes distress since the average of total diabetes distress 
scores might be within normal ranges, yet, the distress subscales might reveal specific distress 
warranting more attention. We observed that moderate-high emotional and regimen diabetes distress 
was higher among the elderly (60-69 years) and patients who could not afford to pay the health 
insurance premium (Table 2). Regimen-related distress is an important area of diabetes distress that 
focuses on patients’ treatment. It might be that elderly patients in this study may have experienced 
more difficulty in managing their diabetes and hypertension regimens concurrently. Furthermore, these 
patients may feel a lack of emotional support as well as have difficulty coping with their condition 
(Baek et al., 2014; Naicker et al., 2017). In addition, patients who could not afford to pay the health 
insurance premium.  Indicating that these patients were those with low economic status. These patients 
might experience a higher emotional burden compared to those with high economic status. Therefore, 
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a behavioral intervention which targeted on the emotional aspect of managing diabetes is needed to 































Figure 1. Percentage of diabetes distress based on subscales 
 





Gender    
  Male 17 (25.8) 8 (21.1) 0,641 
  Female 49 (74.2) 30 (78.9) 
Age in years    
  ≤ 49   1 (1.6) 7 (18.4) 0,014* 
  50–59 19 (29.7) 6 (15.8) 
  60–69 28 (43.8) 16 (42.1) 
  ≥ 70 16 (25.0) 9 (23.7) 
Type of insurance    
  BPJS-PBI 22 (33.3) 22 (57.9) 0,012* 
  BPJS-Non PBI 36 (54.5) 16 (42.1) 
  Without insurance 8 (12.1) 0 
Last education level     
  No formal education/   
  elementary school 
19 (29.7) 12 (31.6) 0,780 
  Junior high school 16 (25.0) 9 (23.7) 
  Senior high school 22 (34.4) 15 (39.5) 
  University 7 (10.9) 2 (5.3) 
Time from diagnosis, years    
  Diabetes, mean (SD) 3.8 (4.0) 4.4 (3.8) 0,289 
  Hypertension, mean (SD) 5.4 (5.7) 4.6 (5.1) 0,285 
Abbreviations: BPJS-PBI: patients who could not afford to pay the health insurance premium, BPJS-Non PBI: 
patients who afford to pay the health insurance premium, SD: standard deviation. 
∗Statistically significant difference (p < 0.05) using Pearson χ2 and Mann–Whitney tests  
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The strength of our study is that our population consists of T2DM patients with hypertension as 
comorbidities, as it is representative of T2DM patients. In addition, the high response rate reported in 
our study indicates our findings are generalizable for T2DM patients who visit the CHCs in Bandung 
City, Indonesia. However, our study might underestimate the level of diabetes distress because of 
social desirability and recall bias. Furthermore, most of the patients participated in our study were 
those who regularly visited the CHCs, which is reflected with most patients experiencing mild 
diabetes distress. Studies evaluating the association between sociodemographic factors and diabetes 
distress in less controlled T2DM patients using antihypertensive medications are therefore needed. 
Our findings highlight a need for a routine diabetes distress assessment among T2DM patients 
with comorbidity in primary care settings, particularly for the elderly and patients who could not 
afford to pay the health insurance premium T2DM patients who experienced moderate-high diabetes 
distress may need early and additional supports from health care providers to address these specific 
areas of diabetes management. 
 
CONCLUSION  
Emotional and regimen distress as a dominant forms of diabetes distress was observed among 
T2DM patients using antihypertensive medications. A routine diabetes distress assessment is needed in 
T2DM patients with comorbidity in primary care settings, particularly for elderly and patients who 
could not afford to pay the health insurance premium. 
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